Application no. and date | 05856121.8 (espacenet) (Federated) (European Patent Register), 20051230 | Patent/reg. no. and date | DK/EP 1830857, 20100915 | Publication date | 20070912 | Priority no. and date | US 640178 P, 20041230 | EP pub. no. and date |
EP 1830857 20070912 | Effective date | | Applicant/owner | Soligenix, Inc., 29 Emmons Drive Suite C-10
Princeton, New Jersey 08540, US | Applicant ref. no. | P81007954DK00E | Inventor | McDONALD, George B., 1815 102nd Place Southeast
Bellevue, WA 98004, US, KANZER, Steve, 300 South Point Drive
Miami Beach, FL 33139, US, STERGIS, Nicholas, 850 Bear Tavern Road, Suite 201
Ewing, NJ 08628, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/573 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 37/06 (2006.01) | Title | Beclomethasondipropionat og prednison til reducering af dødelighed associeret med Graft-Versus-Host sygdom | Int. application no. | US2005047666 | Int. publication no. | WO2006072093 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|